-
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
van Lierop, Z. Y. GJ., Wieske, L., Koel-Simmelink, M. J. A., Chatterjee, M., Dekker, I., Leurs, C. E., Willemse, E. A. J., Moraal, B., Barkhof, F., Eftimov, F., Uitdehaag, B. M. J., Killestein, J. & Teunissen, C. E., Jan 2022, In: MULTIPLE SCLEROSIS JOURNAL. 28, 1, p. 102-110 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
A more unstable resting-state functional network in cognitively declining multiple sclerosis
Broeders, T. A. A., Douw, L., Eijlers, A. J. C., Dekker, I., Uitdehaag, B. M. J., Barkhof, F., Hulst, H. E., Vinkers, C. H., Geurts, J. J. G. & Schoonheim, M. M., 2022, In: Brain Communications. 4, 2, p. fcac095 fcac095.Research output: Contribution to journal › Article › Academic › peer-review
-
Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
Strik, M., Eijlers, A. J. C., Dekker, I., Broeders, T. A. A., Douw, L., Killestein, J., Kolbe, S. C., Geurts, J. J. G. & Schoonheim, M. M., 2022, (E-pub ahead of print) In: MULTIPLE SCLEROSIS JOURNAL.Research output: Contribution to journal › Article › Academic › peer-review
- All publications